Sulfzix Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


SULFZIX is indicated for the clinical dietary management of the metabolic processes of certain individuals with chronic hydrogen sulfide insufficiency that cannot be corrected through diet alone, with a particular emphasis in persons who have inborn errors of cystathionine beta-synthase (CBS), cystathione gamma-lyase (CSE), and/or 3-mercaptopyruvatesulfurtransferase (3-MST). Clinical dietary management in patients who, as a result of a condition or disease, have limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients associated with endogenous hydrogen sulfide biochemistry, with a particular emphasis in patients with heart failure and chronic wounds.1-6 Must be used under licensed medical supervision.

In patients with suboptimal hydrogen sulfide levels, and as determined by your licensed medical practitioner, SULFZIX may be administered as rescue or adjunctive nutritional therapy to address the risk of suboptimal hydrogen sulfide which can lead to oxidative stress, inflammatory, and/or vascular complications.1-4 The adjunctive use of SULFZIX enables medical practitioners to combine therapeutic modalities (dietary management and drug therapy).1


There is currently no drug history available for this drug.

Other Information

SULFZIX is an orally-administered medical food dispensed by prescription for the clinical dietary management of suboptimal hydrogen sulfide levels related to metabolic imbalances in endogenous hydrogen sulfide biochemistry. Use under medical supervision.
Each SULFZIX serving contains:

   Sodium polysulthionate 400 mg
   5-methyltetrahydrofolate 500 mcg

†Proprietary matrix of alpha sulfur, sodium sulfate, sodium thiosulfate obtained by reacting sodium hydrosulfide with sodium metabisulfite in an acidic medium

Sulfzix Manufacturers

  • Basiem
    Sulfzix (Sodium Polysulthionate, 5-methyltetrahydrofolate) Powder [Basiem]

Login To Your Free Account